<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nierengarten, Mary Beth</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Reddy, Vivek Y.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">First-in-Man Results Show That a Leadless Catheter Pacemaker is Feasible, Safe, and Effective</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-22</style></pages><abstract><style  face="normal" font="default" size="100%">Results of a first-in-man study of a novel intracardiac leadless catheter pacemaker (LCP) show its feasibility, safety, and efficacy for right ventricular (RV) pacing, reported study investigators. The prospective, nonrandomized, single-arm LEADLESS study [NCT01700244], conducted at three sites, evaluated the in vivo implantation of the LCP for the first time in 33 patients who required a permanent rate modulated ventricular-based pacemaker.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>